Dynamic Shared Ownership and the Bayer Transition: What is it and Can it Work?
An overview of Humanocracy and considerations of what it looks like within Bayer
Bayer Cuts Dividend by 95% as It Wrestles With Roundup Woes - Bloomberg
Bayer plans to cut its dividend by 95% (to the legal minimum in Germany) in an effort to manage the debt created by the acquisition of Monsanto that has impacted the company because of the extensive litigation surrounding glyphosate.
Even beyond the glyphosate challenges, Bayer is having struggles across its business units.
New CEO Bill Anderson has initiated operational changes designed to speed up decision-making, cutting layers of management and eliminating thousands of jobs. The job cuts will be implemented over the coming months and completed by the end of 2025 at the latest.
Anderson is also reviewing the company strategy, which currently includes three divisions focused on crop science, pharmaceuticals, and consumer health products. We will find out what the go-forward plan is during the company Capital Markets Day on March 5th, so I will cover that in the March 10th edition of Upstream.
Regarding the operational changes, Anderson has been emphasizing what he calls “Dynamic Shared Ownership,” or DSO, based on the book Humanocracy by Gary Hamel.